{
  "drug_name": "Spironolactone",
  "url": "https://wikem.org/wiki/Spironolactone",
  "scraped_at": "2026-01-10T08:02:28.847799",
  "sections": {
    "Administration": {
      "text": "Type:\nAntihypertensive\n;\npotassium sparing diuretic\n; aldosterone receptor antagonist\nDosage Forms: 25,50,100\nRoutes of Administration: Oral\nCommon Trade Names: Aldactone",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "Antihypertensive",
          "url": "https://wikem.org/wiki/Antihypertensive"
        },
        {
          "text": "potassium sparing diuretic",
          "url": "https://wikem.org/wiki/Potassium_sparing_diuretic"
        }
      ]
    },
    "Adult_Dosing": {
      "text": "",
      "subsections": {
        "Edema": {
          "text": "25-200mg/day PO divided QD-bid\nFor edema associated with\nCHF\n,\ncirrhosis\n, or\nnephrotic syndrome",
          "tables": []
        },
        "Hypertension": {
          "text": "25-50mg/day PO divided QD-bid\nStart: 12.5mg PO QD",
          "tables": []
        },
        "Hyperaldosteronism,_primary": {
          "text": "100-400mg PO QD",
          "tables": []
        },
        "Hypokalemia,_diuretic-induced": {
          "text": "25-100mg/day PO divided QD-QID",
          "tables": []
        },
        "CHF,_NYHA_Class_III/IV": {
          "text": "25mg PO QD\nUse with standard treatment; may increase to 50mg/day after 8wk for worsening CHF if K stable\nMay decrease to 25mg qod if hyperkalemia; hold if K >5 mEq/L or creatinine >4mg/dL",
          "tables": []
        },
        "Hirsutism,_idiopathic": {
          "text": "50-200mg PO QD\nOff label use",
          "tables": []
        },
        "Acne_vulgaris": {
          "text": "50-200mg PO QD\nStart: 25mg PO QD\nOff label use",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "CHF",
          "url": "https://wikem.org/wiki/CHF"
        },
        {
          "text": "cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "nephrotic syndrome",
          "url": "https://wikem.org/wiki/Nephrotic_syndrome"
        }
      ]
    },
    "Edema": {
      "text": "25-200mg/day PO divided QD-bid\nFor edema associated with\nCHF\n,\ncirrhosis\n, or\nnephrotic syndrome",
      "subsections": {
        "Hypertension": {
          "text": "25-50mg/day PO divided QD-bid\nStart: 12.5mg PO QD",
          "tables": []
        },
        "Hyperaldosteronism,_primary": {
          "text": "100-400mg PO QD",
          "tables": []
        },
        "Hypokalemia,_diuretic-induced": {
          "text": "25-100mg/day PO divided QD-QID",
          "tables": []
        },
        "CHF,_NYHA_Class_III/IV": {
          "text": "25mg PO QD\nUse with standard treatment; may increase to 50mg/day after 8wk for worsening CHF if K stable\nMay decrease to 25mg qod if hyperkalemia; hold if K >5 mEq/L or creatinine >4mg/dL",
          "tables": []
        },
        "Hirsutism,_idiopathic": {
          "text": "50-200mg PO QD\nOff label use",
          "tables": []
        },
        "Acne_vulgaris": {
          "text": "50-200mg PO QD\nStart: 25mg PO QD\nOff label use",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "CHF",
          "url": "https://wikem.org/wiki/CHF"
        },
        {
          "text": "cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "nephrotic syndrome",
          "url": "https://wikem.org/wiki/Nephrotic_syndrome"
        }
      ]
    },
    "Hypertension": {
      "text": "25-50mg/day PO divided QD-bid\nStart: 12.5mg PO QD",
      "subsections": {
        "Hyperaldosteronism,_primary": {
          "text": "100-400mg PO QD",
          "tables": []
        },
        "Hypokalemia,_diuretic-induced": {
          "text": "25-100mg/day PO divided QD-QID",
          "tables": []
        },
        "CHF,_NYHA_Class_III/IV": {
          "text": "25mg PO QD\nUse with standard treatment; may increase to 50mg/day after 8wk for worsening CHF if K stable\nMay decrease to 25mg qod if hyperkalemia; hold if K >5 mEq/L or creatinine >4mg/dL",
          "tables": []
        },
        "Hirsutism,_idiopathic": {
          "text": "50-200mg PO QD\nOff label use",
          "tables": []
        },
        "Acne_vulgaris": {
          "text": "50-200mg PO QD\nStart: 25mg PO QD\nOff label use",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hyperaldosteronism,_primary": {
      "text": "100-400mg PO QD",
      "subsections": {
        "Hypokalemia,_diuretic-induced": {
          "text": "25-100mg/day PO divided QD-QID",
          "tables": []
        },
        "CHF,_NYHA_Class_III/IV": {
          "text": "25mg PO QD\nUse with standard treatment; may increase to 50mg/day after 8wk for worsening CHF if K stable\nMay decrease to 25mg qod if hyperkalemia; hold if K >5 mEq/L or creatinine >4mg/dL",
          "tables": []
        },
        "Hirsutism,_idiopathic": {
          "text": "50-200mg PO QD\nOff label use",
          "tables": []
        },
        "Acne_vulgaris": {
          "text": "50-200mg PO QD\nStart: 25mg PO QD\nOff label use",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hypokalemia,_diuretic-induced": {
      "text": "25-100mg/day PO divided QD-QID",
      "subsections": {
        "CHF,_NYHA_Class_III/IV": {
          "text": "25mg PO QD\nUse with standard treatment; may increase to 50mg/day after 8wk for worsening CHF if K stable\nMay decrease to 25mg qod if hyperkalemia; hold if K >5 mEq/L or creatinine >4mg/dL",
          "tables": []
        },
        "Hirsutism,_idiopathic": {
          "text": "50-200mg PO QD\nOff label use",
          "tables": []
        },
        "Acne_vulgaris": {
          "text": "50-200mg PO QD\nStart: 25mg PO QD\nOff label use",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "CHF,_NYHA_Class_III/IV": {
      "text": "25mg PO QD\nUse with standard treatment; may increase to 50mg/day after 8wk for worsening CHF if K stable\nMay decrease to 25mg qod if hyperkalemia; hold if K >5 mEq/L or creatinine >4mg/dL",
      "subsections": {
        "Hirsutism,_idiopathic": {
          "text": "50-200mg PO QD\nOff label use",
          "tables": []
        },
        "Acne_vulgaris": {
          "text": "50-200mg PO QD\nStart: 25mg PO QD\nOff label use",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hirsutism,_idiopathic": {
      "text": "50-200mg PO QD\nOff label use",
      "subsections": {
        "Acne_vulgaris": {
          "text": "50-200mg PO QD\nStart: 25mg PO QD\nOff label use",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Acne_vulgaris": {
      "text": "50-200mg PO QD\nStart: 25mg PO QD\nOff label use",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pediatric_Dosing": {
      "text": "",
      "subsections": {
        "Edema_2": {
          "text": "1-3.3mg/kg/day PO divided QD-QID\nMax: 3.3mg/kg/day up to 200mg/day\nOff label use",
          "tables": []
        },
        "Hyperaldosteronism_test": {
          "text": "125-375mg/m^2/day PO divided bid-QID\nMax: 375mg/m^2/day\nOff label use",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Edema_2": {
      "text": "1-3.3mg/kg/day PO divided QD-QID\nMax: 3.3mg/kg/day up to 200mg/day\nOff label use",
      "subsections": {
        "Hyperaldosteronism_test": {
          "text": "125-375mg/m^2/day PO divided bid-QID\nMax: 375mg/m^2/day\nOff label use",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hyperaldosteronism_test": {
      "text": "125-375mg/m^2/day PO divided bid-QID\nMax: 375mg/m^2/day\nOff label use",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Special_Populations": {
      "text": "Pregnancy Risk Factor\n: C",
      "subsections": {
        "Renal_Dosing": {
          "text": "CrCl <10, anuria, or acute renal impairment: contraindicated",
          "tables": []
        },
        "Hepatic_Dosing": {
          "text": "Caution advised with hepatic impairment",
          "tables": []
        }
      },
      "tables": [],
      "links": [
        {
          "text": "Pregnancy Risk Factor",
          "url": "https://wikem.org/wiki/Drug_ratings_in_pregnancy"
        }
      ]
    },
    "Renal_Dosing": {
      "text": "CrCl <10, anuria, or acute renal impairment: contraindicated",
      "subsections": {
        "Hepatic_Dosing": {
          "text": "Caution advised with hepatic impairment",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Hepatic_Dosing": {
      "text": "Caution advised with hepatic impairment",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Contraindications": {
      "text": "Allergy to class/drug\nCrCl <10\nanuria\nrenal impairment, acute\nhyperkalemia\nAddison disease",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "hyperkalemia",
          "url": "https://wikem.org/wiki/Hyperkalemia"
        }
      ]
    },
    "Adverse_Reactions": {
      "text": "",
      "subsections": {
        "Serious": {
          "text": "anaphylaxis\nStevens-Johnson syndrome\ntoxic epidermal necrolysis\ndrug reaction with eosinophilia and systemic sx\nvasculitis\nhepatotoxicity\nrenal failure\nelectrolyte imbalance\nhyperkalemia, severe\narrhythmias\nleukopenia\nagranulocytosis\nthrombocytopenia",
          "tables": []
        },
        "Common": {
          "text": "nausea/vomiting\nabdominal cramps/pain\nmuscle cramps\ndiarrhea\nheadache\nconfusion\ndizziness\nsomnolence",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Serious": {
      "text": "anaphylaxis\nStevens-Johnson syndrome\ntoxic epidermal necrolysis\ndrug reaction with eosinophilia and systemic sx\nvasculitis\nhepatotoxicity\nrenal failure\nelectrolyte imbalance\nhyperkalemia, severe\narrhythmias\nleukopenia\nagranulocytosis\nthrombocytopenia",
      "subsections": {
        "Common": {
          "text": "nausea/vomiting\nabdominal cramps/pain\nmuscle cramps\ndiarrhea\nheadache\nconfusion\ndizziness\nsomnolence",
          "tables": []
        }
      },
      "tables": [],
      "links": []
    },
    "Common": {
      "text": "nausea/vomiting\nabdominal cramps/pain\nmuscle cramps\ndiarrhea\nheadache\nconfusion\ndizziness\nsomnolence",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Pharmacology": {
      "text": "Half-life: 1.3-2h (parent drug), 13.8-16.5h (active metabolites)\nMetabolism: Liver\nExcretion: Urine",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "Mechanism_of_Action": {
      "text": "Antagonizes aldosterone receptors in the distal convoluted tubule, decreasing Na and water reabsorption and increasing K retention",
      "subsections": {},
      "tables": [],
      "links": []
    },
    "See_Also": {
      "text": "CHF\nCirrhosis\n,\nAscites",
      "subsections": {},
      "tables": [],
      "links": [
        {
          "text": "CHF",
          "url": "https://wikem.org/wiki/CHF"
        },
        {
          "text": "Cirrhosis",
          "url": "https://wikem.org/wiki/Cirrhosis"
        },
        {
          "text": "Ascites",
          "url": "https://wikem.org/wiki/Ascites"
        }
      ]
    },
    "References": {
      "text": "<Epocrates, UpToDate>",
      "subsections": {},
      "tables": [],
      "links": []
    }
  }
}